Michael J. Sofia serves as Executive at Arbutus Biopharma Corp, where they oversee executive responsibilities. Since joining the company, Michael J. Sofia has executed 14 insider transactions totaling $1.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 2, 2024 involved selling 9,982 shares valued at $23.1K.
Michael J. Sofia currently holds 1,485,121 shares of Arbutus Biopharma Corp (ABUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael J. Sofia has been a net seller of ABUS stock. They have purchased $0 and sold $1.8M worth of shares.
Michael J. Sofia's most recent insider trade was on Feb 2, 2024, when they sold 9,982 shares at $2.31 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Planned |
| Feb 1, 2023 | ABUS | $0 | Award | 82,200 | $N/A | Discretionary |
| Dec 1, 2021 | ABUS | $1.0M | Sale | 200,000 | $5.09 | Discretionary |
| Aug 13, 2018 | ABUS | $40.4K | Sale | 4,250 | $9.51 | Discretionary |
| Aug 13, 2018 | ABUS | $40.4K | Sale | 4,250 | $9.51 | Discretionary |
| Jul 11, 2018 | ABUS | $100.0K | Sale | 10,000 | $10.00 | Discretionary |
| Jul 9, 2018 | ABUS | $89.1K | Sale | 10,000 | $8.91 | Discretionary |
| Jul 6, 2018 | ABUS | $84.5K | Sale | 10,000 | $8.45 | Discretionary |
| Jul 5, 2018 | ABUS | $84.0K | Sale | 10,000 | $8.40 | Discretionary |
| Jul 3, 2018 | ABUS | $80.0K | Sale | 10,000 | $8.00 | Discretionary |
| Oct 3, 2017 | ABUS | $80.0K | Sale | 10,000 | $8.00 | Discretionary |
| Aug 15, 2017 | ABUS | $37.5K | Sale | 10,000 | $3.75 | Discretionary |
| Aug 15, 2017 | ABUS | $73.6K | Sale | 20,000 | $3.68 | Discretionary |